Hikma Pharmaceuticals PLC (HIK) - Stock & Dividends

Hikma Pharmaceuticals PLC, traded on the London Stock Exchange under the symbol HIK, is a company that specializes in developing, manufacturing, marketing, and selling a wide range of pharmaceutical products. They offer generic, branded, and in-licensed medications in solid, semi-solid, liquid, and injectable forms.

The company operates in various regions, including North America, the Middle East, North Africa, and Europe. They have three main segments: Injectables, Generics, and Branded. The Injectables division focuses on generic injectable products primarily used in hospitals, while the Generics segment provides non-injectable generic products for retail distribution. The Branded segment offers branded generics and in-licensed medications to both retail and hospital markets.

Hikma Pharmaceuticals PLC caters to diverse therapeutic areas such as respiratory, oncology, and pain management. Established in 1978 and headquartered in London, United Kingdom, the company has positioned itself as a key player in the pharmaceutical industry. To learn more about their products and services, visit their website: https://www.hikma.com